{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:10:43Z","timestamp":1792080643775,"version":"4.4.0"},"reference-count":27,"publisher":"American Psychiatric Association Publishing","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AJP"],"published-print":{"date-parts":[[2002,1,1]]},"DOI":"10.1176\/appi.ajp.159.1.96","type":"journal-article","created":{"date-parts":[[2002,10,11]],"date-time":"2002-10-11T18:20:39Z","timestamp":1034360439000},"page":"96-102","source":"Crossref","is-referenced-by-count":158,"title":["A Placebo-Controlled Study of Fluoxetine in Continued Treatment of Bulimia Nervosa After Successful Acute Fluoxetine Treatment"],"prefix":"10.1176","volume":"159","author":[{"given":"Steven J.","family":"Romano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine A.","family":"Halmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neena P.","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie C.","family":"Koke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"230","reference":[{"key":"R1591BCGHCGDJ","doi-asserted-by":"crossref","unstructured":"Herzog DB, Nussbaum KM, Marmor AK: Comorbidity and outcome in eating disorders. Psychiatr Clin North Am 1996; 19:843-859","DOI":"10.1016\/S0193-953X(05)70385-3"},{"key":"R1591BCGHCBJB","doi-asserted-by":"crossref","unstructured":"Kendler KS, MacLean C, Neale M, Kessler R, Heath A, Eaves L: The genetic epidemiology of bulimia nervosa. Am J Psychiatry 1991; 148:1627-1637","DOI":"10.1176\/ajp.148.12.1627"},{"key":"R1591BCGCBGGE","doi-asserted-by":"crossref","unstructured":"Brewerton TD, Mueller EA, Lesem MD, Brandt HA, Quearry B, George DT, Murphy DL, Jimerson DC: Neuroendocrine responses to m-chlorophenylpiperazine and l-tryptophan in bulimia. Arch Gen Psychiatry 1992; 49:852-861","DOI":"10.1001\/archpsyc.1992.01820110016002"},{"key":"R1591BCGIJIFA","unstructured":"McBride PA, Anderson GM, Khait VD, Sunday SR, Halmi KA: Serotonergic responsivity in eating disorders. Psychopharmacol Bull 1991; 27:365-372"},{"key":"R1591BCGGIDFI","doi-asserted-by":"crossref","unstructured":"Jimerson DC, Herzog DB: Pharmacologic approaches in the treatment of eating disorders. Harv Rev Psychiatry 1993; 1:82-93","DOI":"10.3109\/10673229309017063"},{"key":"R1591BCGCHDDH","doi-asserted-by":"crossref","unstructured":"Pope HG Jr, Hudson JI, Jonas JM, Yurgelun-Todd D: Bulimia treated with imipramine: a placebo-controlled, double-blind study. Am J Psychiatry 1983; 140:554-558","DOI":"10.1176\/ajp.140.5.554"},{"key":"atypb1","doi-asserted-by":"crossref","unstructured":"Hughes PL, Wells LA, Cunningham CJ, Ilstrup DM: Treating bulimia with desipramine: a placebo-controlled double-blind study. Arch Gen Psychiatry 1986; 43:182-186","DOI":"10.1001\/archpsyc.1986.01800020092012"},{"key":"atypb2","doi-asserted-by":"crossref","unstructured":"Agras WS, Dorian BG, Kirkley BG, Arnow B, Bachman J: Imipramine in the treatment of bulimia: a double-blind controlled study. Int J Eat Disord 1987; 6:29-38","DOI":"10.1002\/1098-108X(198701)6:1<29::AID-EAT2260060105>3.0.CO;2-2"},{"key":"atypb4","unstructured":"Price WA, Babai MR: Antidepressant drug therapy for bulimia: current status revisited (letter). J Clin Psychiatry 1987; 48:385"},{"key":"atypb5","doi-asserted-by":"crossref","unstructured":"Barlow J, Blouin J, Blouin A, Perez E: Treatment of bulimia with desipramine: a double-blind crossover study. Can J Psychiatry 1988; 33:129-133","DOI":"10.1177\/070674378803300211"},{"key":"atypb6","unstructured":"Horne RL, Ferguson JM, Pope HG Jr, Hudson JI, Lineberry CG, Ascher J, Cato A: Treatment of bulimia with bupropion: a multicenter controlled trial. J Clin Psychiatry 1988; 49:262-266"},{"key":"atypb7","doi-asserted-by":"crossref","unstructured":"Walsh BT, Gladis M, Rose SP, Stewart JW, Stetner F, Glassman AH: Phenelzine vs placebo in 50 patients with bulimia. Arch Gen Psychiatry 1988; 45:471-475","DOI":"10.1001\/archpsyc.1988.01800290091011"},{"key":"atypb8","doi-asserted-by":"crossref","unstructured":"Kennedy SH, Piran N, Warsh JJ, Prendergast P, Mainprize E, Whynot C, Garfinkel PE: A trial of isocarboxazid in the treatment of bulimia nervosa. J Clin Psychopharmacol 1988; 8:391-396","DOI":"10.1097\/00004714-198812000-00002"},{"key":"R1591BCGBGIHI","doi-asserted-by":"crossref","unstructured":"Pope HG Jr, Keck PE Jr, McElroy SM, Hudson JI: A placebo-controlled study of trazodone in bulimia nervosa. J Clin Psychopharmacol 1989; 9:254-259","DOI":"10.1097\/00004714-198908000-00004"},{"key":"R1591BCGFHCFF","doi-asserted-by":"crossref","unstructured":"Fichter MM, Leibl K, Rief W, Brunner E, Schmidt-Auberger S, Engel RR: Fluoxetine versus placebo: a double-blind study with bulimic inpatients undergoing intensive psychotherapy. Pharmacopsychiatry 1991; 24:1-7","DOI":"10.1055\/s-2007-1014424"},{"key":"R1591BCGBJEHF","doi-asserted-by":"crossref","unstructured":"Fluoxetine Bulimia Nervosa Collaborative Study Group: Fluoxetine in the treatment of bulimia nervosa: a multicenter, placebo-controlled, double-blind trial. Arch Gen Psychiatry 1992; 49:139-147","DOI":"10.1001\/archpsyc.1992.01820020059008"},{"key":"R1591BCGDJIHD","doi-asserted-by":"crossref","unstructured":"Goldstein DJ, Wilson MG, Thompson VL, Potvin JH, Rampey AH (Fluoxetine Bulimia Nervosa Research Group): Long-term fluoxetine treatment of bulimia nervosa. Br J Psychiatry 1995; 166:660-666","DOI":"10.1192\/bjp.166.5.660"},{"key":"R1591BCGCEDCG","doi-asserted-by":"crossref","unstructured":"Keel PK, Mitchell JE: Outcome in bulimia nervosa. Am J Psychiatry 1997; 154:313-321","DOI":"10.1176\/ajp.154.3.313"},{"key":"R1591BCGBJGDG","doi-asserted-by":"crossref","unstructured":"Mazure CM, Halmi KA, Sunday SR, Romano SJ, Einhorn AM: The Yale-Brown-Cornell Eating Disorder Scale: development, use, reliability, and validity. J Psychiatr Res 1994; 28:425-445","DOI":"10.1016\/0022-3956(94)90002-7"},{"key":"R1591BCGBJDEE","doi-asserted-by":"crossref","unstructured":"Hamilton M: Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967; 6:278-296","DOI":"10.1111\/j.2044-8260.1967.tb00530.x"},{"key":"R1591BCGCBBHF","doi-asserted-by":"crossref","unstructured":"Gray RJ, Tsiatis AA: A linear rank test for use when the main interest is in difference in cure rates. Biometrics 1989; 45:899-904","DOI":"10.2307\/2531691"},{"key":"R1591BCGDCHFD","doi-asserted-by":"crossref","unstructured":"Akritas MG, Arnold SF, Brunner E: Nonparametric hypotheses and rank statistics for unbalanced factorial designs. J Am Statistical Assoc 1997; 92:258-265","DOI":"10.1080\/01621459.1997.10473623"},{"key":"R1591BCGCBHEB","doi-asserted-by":"crossref","unstructured":"Mitchell JE, Raymond N, Specker S: A review of the controlled trials of pharmacotherapy and psychotherapy in the treatment of bulimia nervosa. Int J Eat Disord 1993; 14:229-247","DOI":"10.1002\/1098-108X(199311)14:3<229::AID-EAT2260140302>3.0.CO;2-X"},{"key":"R1591BCGDIEAE","doi-asserted-by":"crossref","unstructured":"Goldbloom DS, Olmsted M, Davis R, Clewes J, Heinmaa M, Rockert W, Shaw B: A randomized controlled trial of fluoxetine and cognitive behavioral therapy for bulimia nervosa: short-term outcome. Behav Res Ther 1997; 35:803-811","DOI":"10.1016\/S0005-7967(97)00041-7"},{"key":"R1591BCGJFIBB","doi-asserted-by":"crossref","unstructured":"Mitchell JE, Pyle RL, Eckert ED, Hatsukami D, Pomeroy C, Zimmerman R: Comparison study of antidepressants and structured intensive group psychotherapy in the treatment of bulimia nervosa. Arch Gen Psychiatry 1990; 47:149-157","DOI":"10.1001\/archpsyc.1990.01810140049008"},{"key":"R1591BCGDJHJC","doi-asserted-by":"crossref","unstructured":"Agras WS, Rossiter EM, Arnow B, Schneider JA, Telch CF, Raeburn SD, Bruce B, Perl M, Koran LM: Pharmacologic and cognitive-behavioral treatment for bulimia nervosa: a controlled comparison. Am J Psychiatry 1992; 149:82-87","DOI":"10.1176\/ajp.149.1.82"},{"key":"R1591BCGDEEHH","doi-asserted-by":"crossref","unstructured":"Walsh BT, Wilson GT, Loeb KL, Devlin MJ, Pike KM, Roose SP, Fleiss J, Waternaux C: Medication and psychotherapy in the treatment of bulimia nervosa. Am J Psychiatry 1997; 154:523-531","DOI":"10.1176\/ajp.154.4.523"}],"container-title":["American Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.159.1.96","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T19:09:20Z","timestamp":1722366560000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.159.1.96"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,1,1]]}},"alternative-id":["10.1176\/appi.ajp.159.1.96"],"URL":"https:\/\/doi.org\/10.1176\/appi.ajp.159.1.96","relation":{},"ISSN":["0002-953X","1535-7228"],"issn-type":[{"value":"0002-953X","type":"print"},{"value":"1535-7228","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,1,1]]}}}